Factors related to The incidence of preeclampsia in Sunan Kudus Hospital

Nia  Ilhammatul Ulla; Noor Hidayah; Edy Soesanto

doi:10.51601/ijhp.v6i1.584

Authors

Nia Ilhammatul Ulla Universitas Muhammadiyah Kudus, Jawa Tengah, Indonesia
Noor Hidayah Universitas Muhammadiyah Kudus, Jawa Tengah, Indonesia
Edy Soesanto Universitas Muhammadiyah Kudus, Jawa Tengah, Indonesia

DOI:

https://doi.org/10.51601/ijhp.v6i1.584

Abstract

Preeclampsia is one of the main causes of maternal morbidity and mortality in Indonesia which is characterized by increased blood pressure and impaired organ function after 20 weeks of gestation. This study aims to determine the relationship between diabetes mellitus, anemia, and the distance between pregnancies and the incidence of preeclampsia in pregnant women who give birth at Sunan Kudus Hospital in 2024. This study used a quantitative design with a retrospective case-control approach, involving 252 respondents consisting of 63 pregnant women with preeclampsia (cases) and 189 pregnant women without preeclampsia (control). Data were collected secondary through medical records and analyzed using the Chi-Square test with a 95% confidence level and p< significance of 0.05. The results showed that diabetes mellitus was not significantly associated with the incidence of preeclampsia (p = 0.096; OR = 2,737; CI 0.884–8.475), but mothers with DM have a 2.7-fold greater risk of developing preeclampsia. There was a significant association between anemia and the incidence of preeclampsia (p = 0.001; OR = 2,794; CI 1.520–5.136) and between the distance between pregnancy and the incidence of preeclampsia (p = 0.022; OR = 2,053; CI 1,146–3,679). In conclusion, anemia and the distance between pregnancies at risk have a meaningful relationship with the incidence of preeclampsia, whereas diabetes mellitus is not statistically significant but still has the potential to increase risk. Prevention of preeclampsia needs to be focused on monitoring hemoglobin levels, setting ideal pregnancy distances, and managing metabolic diseases during pregnancy through comprehensive antenatal care examinations.

Downloads

Download data is not yet available.

References

[1] ACOG. (2021). Preeclampsia and Pregnancy. The American College of Obstetricians and Gynecologists. https://www.acog.org/womens-health/infographics/preeclampsia-and-pregnancy

[2] Adli, F. K. (2021). Gestational Diabetes Mellitus: Diagnosis and Risk Factors. Journal of Medika Hutama, 03(01), 1545–1551.

[3] Akil, A. A. S., Yassin, E., Al-Maraghi, A., Aliyev, E., Al-Malki, K., & Fakhro, K. A. (2021). Diagnosis and treatment of type 1 diabetes at the dawn of the personalized medicine era. Journal of Translational Medicine, 19(1), 1–19. https://doi.org/10.1186/s12967-021-02778-6

[4] Ambarwati, R., Sari, Y. N. E., & Natali, M. S. (2023). The Relationship Of Compliance With Aspilet Drinking In Pregnant Women, The Risk Of Preeclampsia And The Incident Of Eclampsia. JKM (Journal of Midwifery Malahayati), 9(4), 682–689. https://doi.org/10.33024/jkm.v9i4.10519

[5] Bernolian, N., Pangemanan, W. T., Kurdi Syamsuri, A., Hatta Ansyori, M., Mirani, P., Maulina Lestari, P., & Martadiansyah, A. (2019). Postsaline Preeclampsia. Indonesian Journal of Obstetrics & Gynecology Science, 23–33.

[6] Iffat Imran Nazir, Balqees Awaad Alharthi, H. A. A. (2019). Short Inter-Pregnancy Interval as a Risk Factor for Anaemia in Pregnancy. EC Microbiology, 15(12), 148–157. https://www.ecronicon.com/ecmi/pdf/ECMI-15-00768.pdf

[7] İmamoğlu, M., Şimşek, D., Dinçgez, B., Ünal, S., Demirci, A., İlhan, O., İmamoğlu, A. G., & Özçeltik, G. (2022). Short interdelivery interval in modern obstetrics: Maternal and neonatal outcomes. Clinical Investigation, 19(4), 295–301. https://doi.org/10.4274/tjod.galenos.2022.50576

[8] Issat, T., Pankiewicz, K., Szczerba, E., Fijałkowska, A., & Sierdzi, J. (2022). The Impact of Coexisting Gestational Diabetes Mellitus on the Course of Preeclampsia. Journal of Clinical Medicine Article, 11. https://doi.org/https://doi.org/10.3390/jcm11216390

[9] Ives, C. W., Sinkey, R., Rajapreyar, I., Tita, A. T. N., & Oparil, S. (2020). Preeclampsia—Pathophysiology and Clinical Presentations: JACC State-of-the-Art Review. Journal of the American College of Cardiology, 76(14), 1690–1702. https://doi.org/10.1016/j.jacc.2020.08.014

[10] Moon, J. S., Kang, S., Choi, J. H., Lee, K. A., Moon, J. H., Chon, S., Kim, D. J., Kim, H. J., Seo, J. A., Kim, M. K., Lim, J. H., Song, Y. J., Yang, Y. S., Kim, J. H., Lee, Y. Bin, Noh, J., Hur, K. Y., Park, J. S., Rhee, S. Y., ... Lee, B. W. (2024). 2023 Clinical Practice Guidelines for Diabetes Management in Korea: Full Version Recommendation of the Korean Diabetes Association. Diabetes and Metabolism Journal, 48(4), 546–708.

[11] Mufdillah, Ningsih, S. R., Subarto, C. B., & Fajarini, N. (2019). Diabetes Mellitus in Pregnancy. chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/http://digilib.unisayogya.ac.id/4254/1/Knowing and Trying to Overcome Diabetes in Pregnancy - FIX.pdf

[12] Murtiningsih, M. K., Pandelaki, K., & Sedli, B. P. (2021). Lifestyle as a Risk Factor for Type 2 Diabetes Mellitus. E-CliniC, 9(2), 328. https://doi.org/10.35790/ecl.v9i2.32852

[13] Nanda, A. W., & Semarawisma, A. (2022). Association between anemia and preeclampsia : a case control study in Gorontalo region , Indonesia. International Journal of Research in Medical Sciences, 10(1), 31–35.

[14] Ni, W., Gao, X., Su, X., Cai, J., Zhang, S., Zheng, L., Liu, J., Feng, Y., Chen, S., Ma, J., Cao, W., & Zeng, F. (2023). Birth spacing and risk of adverse pregnancy and birth outcomes: A systematic review and dose–response meta‐analysis. Acta Obstetricia et Gynecologica Scandinavica, 102(12), 1618–1633.

[15] Ningsih, F. (2020). Antenatal Care Compliance with the Incidence of Preeclampsia in Pregnant Women at the Kayon Health Center, Palangkaraya City. Journal of Medical Radiation, 6(1), 96–100.

[16] Noor, R. (2024). Risk factors related to the incidence of preeclampsia in pregnant women at RSIA Siti Khadijah 1 Makassar in 2020-2021. Journal Of Social Science Research, 4(2), 6421–6434.

[17] Saito, S., Tsuda, S., & Nakashima, A. (2023). T cell immunity and the etiology and pathogenesis of preeclampsia. Journal of Reproductive Immunology, 159.

[18] WHO. (2021). Maternal mortality. World Health Organization. https://www.who.int/europe/news-room/fact-sheets/item/maternal-mortality

[19] WHO. (2023). Pre-eclampsia. World Health Organization. https://www.who.int/news-room/fact-sheets/detail/pre-eclampsia?utm_source=chatgpt.com

[20] WHO. (2024). Diabetes. World Health Organization. https://www.who.int/news-

[21] Fetal Childbirth or Gestational Diabetes Mellitus. Research Square, 1–13.